Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Burman

Showing results (331-340 of 437) with videos related to

Pageof 44
Sort By:
Critical Care Medicine|February 1, 1983
T3 may be a better agent than T4 in the critically ill hypothyroid patient: evaluation of transport across the blood-brain barrier in a primate modelB Chernow, K D Burman, D L Johnson, et al.
The Journal of Clinical Endocrinology and Metabolism|November 1, 1980
Glucagon kinetics in fasting: physiological elevations in serum 3,5,3'-triiodothyronine increase the metabolic clearance rate of glucagonK D Burman, R C Smallridge, L Jones, et al.
Neuroimage|September 19, 2006
Weaker top-down modulation from the left inferior frontal gyrus in childrenTali Bitan, Douglas D Burman, Dong Lu, et al.
Thyroid : Official Journal of the American Thyroid Association|May 18, 2010
Salivary gland malignancy and radioiodine therapy for thyroid cancerJoanna Klubo-Gwiezdzinska, Douglas Van Nostrand, Kenneth D Burman, et al.
Clinical and Diagnostic Laboratory Immunology|September 25, 1997
Soluble interleukin-2 receptor is a thyroid hormone-dependent early-response marker in the treatment of thyrotoxicosisR C Smallridge, G C Tsokos, K D Burman, et al.
AJR. American Journal of Roentgenology|September 20, 2002
Using morphologic parameters of extraocular muscles for diagnosis and follow-up of Graves' ophthalmopathy: diameters, areas, or volumes?Zsolt Szucs-Farkas, Judit Toth, Erzsebet Balazs, et al.
Journal of the American College of Surgeons|March 15, 2022
Clinical Factors Predictive of Lymph Node Metastasis in Thyroid Cancer Patients: A Multivariate AnalysisHui Zheng, Victoria Lai, Jana Lu, et al.
Metabolism: Clinical and Experimental|June 1, 1978
Failure of 3,3'-diiodothyronine administration to alter TSH and prolactin responses to TRH stimulationK D Burman, R C Dimond, Y Y Djuh, et al.
Thyroid : Official Journal of the American Thyroid Association|September 8, 2009
Utility of the radioiodine whole-body retention at 48 hours for modifying empiric activity of 131-iodine for the treatment of metastatic well-differentiated thyroid carcinomaDouglas Van Nostrand, Frank Atkins, Shari Moreau, et al.
Molecular Carcinogenesis|September 21, 2004
Chronic expression of RET/PTC 3 enhances basal and insulin-stimulated PI3 kinase/AKT signaling and increases IRS-2 expression in FRTL-5 thyroid cellsEri Miyagi, Milena Braga-Basaria, Elena Hardy, et al.
Pageof 44

Showing results (331-340 of 437) with videos related to

Sort By:
Pageof 44
Critical Care Medicine|February 1, 1983
T3 may be a better agent than T4 in the critically ill hypothyroid patient: evaluation of transport across the blood-brain barrier in a primate modelB Chernow, K D Burman, D L Johnson, et al.
The Journal of Clinical Endocrinology and Metabolism|November 1, 1980
Glucagon kinetics in fasting: physiological elevations in serum 3,5,3'-triiodothyronine increase the metabolic clearance rate of glucagonK D Burman, R C Smallridge, L Jones, et al.
Neuroimage|September 19, 2006
Weaker top-down modulation from the left inferior frontal gyrus in childrenTali Bitan, Douglas D Burman, Dong Lu, et al.
Thyroid : Official Journal of the American Thyroid Association|May 18, 2010
Salivary gland malignancy and radioiodine therapy for thyroid cancerJoanna Klubo-Gwiezdzinska, Douglas Van Nostrand, Kenneth D Burman, et al.
Clinical and Diagnostic Laboratory Immunology|September 25, 1997
Soluble interleukin-2 receptor is a thyroid hormone-dependent early-response marker in the treatment of thyrotoxicosisR C Smallridge, G C Tsokos, K D Burman, et al.
AJR. American Journal of Roentgenology|September 20, 2002
Using morphologic parameters of extraocular muscles for diagnosis and follow-up of Graves' ophthalmopathy: diameters, areas, or volumes?Zsolt Szucs-Farkas, Judit Toth, Erzsebet Balazs, et al.
Journal of the American College of Surgeons|March 15, 2022
Clinical Factors Predictive of Lymph Node Metastasis in Thyroid Cancer Patients: A Multivariate AnalysisHui Zheng, Victoria Lai, Jana Lu, et al.
Metabolism: Clinical and Experimental|June 1, 1978
Failure of 3,3'-diiodothyronine administration to alter TSH and prolactin responses to TRH stimulationK D Burman, R C Dimond, Y Y Djuh, et al.
Thyroid : Official Journal of the American Thyroid Association|September 8, 2009
Utility of the radioiodine whole-body retention at 48 hours for modifying empiric activity of 131-iodine for the treatment of metastatic well-differentiated thyroid carcinomaDouglas Van Nostrand, Frank Atkins, Shari Moreau, et al.
Molecular Carcinogenesis|September 21, 2004
Chronic expression of RET/PTC 3 enhances basal and insulin-stimulated PI3 kinase/AKT signaling and increases IRS-2 expression in FRTL-5 thyroid cellsEri Miyagi, Milena Braga-Basaria, Elena Hardy, et al.
Pageof 44